The upregulation of B7-H3 in CRC is closely associated with more advanced tumors and a more aggressive disease phenotype, which includes a higher TNM stage, a larger tumor size, and the presence of lymph node metastasis [98]. This evidence concerns the gene CD276 and metastatic malignant neoplasm in the lymph nodes.